152
Views
0
CrossRef citations to date
0
Altmetric
SHORT REPORT

Metagenomic Next-Generation Sequencing for Diagnostically Challenging Mucormycosis in Patients with Hematological Malignancies

, , , , , , , & show all
Pages 7509-7517 | Received 21 Oct 2022, Accepted 26 Nov 2022, Published online: 19 Dec 2022

References

  • Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis. 2008;47(4):503–509. doi:10.1086/590004
  • Jeong SJ, Lee JU, Song YG, Lee KH, Lee MJ. Delaying diagnostic procedure significantly increases mortality in patients with invasive mucormycosis. Mycoses. 2015;58(12):746–752. doi:10.1111/myc.12428
  • Chamilos G, Marom EM, Lewis RE, Lionakis MS, Kontoyiannis DP. Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Clin Infect Dis. 2005;41(1):60–66. doi:10.1086/430710
  • Lass-Florl C, Resch G, Nachbaur D, et al. The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients. Clin Infect Dis. 2007;45(7):e101–4. doi:10.1086/521245
  • Skiada A, Lanternier F, Groll AH, et al. Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3). Haematologica. 2013;98(4):492–504. doi:10.3324/haematol.2012.065110
  • Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634–653. doi:10.1086/432579
  • Walsh TJ, Gamaletsou MN, McGinnis MR, Hayden RT, Kontoyiannis DP. Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis). Clin Infect Dis. 2012;54(Suppl 1):S55–60. doi:10.1093/cid/cir868
  • Bellanger AP, Grenouillet F, Henon T, et al. Retrospective assessment of beta-D-(1,3)-glucan for presumptive diagnosis of fungal infections. APMIS. 2011;119(4–5):280–286. doi:10.1111/j.1600-0463.2011.02728.x
  • Grumaz S, Stevens P, Grumaz C, et al. Next-generation sequencing diagnostics of bacteremia in septic patients. Genome Med. 2016;8(1):73. doi:10.1186/s13073-016-0326-8
  • Yang L, Song J, Wang Y, Feng J. Metagenomic next-generation sequencing for pulmonary fungal infection diagnosis: lung biopsy versus bronchoalveolar lavage fluid. Infect Drug Resist. 2021;14:4333–4359. doi:10.2147/IDR.S333818
  • Donnelly JP, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020;71(6):1367–1376. doi:10.1093/cid/ciz1008
  • Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754–1760. doi:10.1093/bioinformatics/btp324
  • Skiada A, Pavleas I, Drogari-Apiranthitou M. Epidemiology and diagnosis of mucormycosis: an update. J Fungi. 2020;6(4):265. doi:10.3390/jof6040265
  • Tedder M, Spratt J, Anstadt M, Hegde S, Tedder S, Lowe J. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg. 1994;57(4):1044–1050. doi:10.1016/0003-4975(94)90243-7
  • Miao Q, Ma Y, Wang Q, et al. Microbiological diagnostic performance of metagenomic next-generation sequencing when applied to clinical practice. Clin Infect Dis. 2018;67(suppl_2):S231–S40. doi:10.1093/cid/ciy693
  • Gu W, Deng X, Lee M, et al. Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids. Nat Med. 2021;27(1):115–124. doi:10.1038/s41591-020-1105-z
  • Besser J, Carleton HA, Gerner-Smidt P, Lindsey RL, Trees E. Next-generation sequencing technologies and their application to the study and control of bacterial infections. Clin Microbiol Infect. 2018;24(4):335–341. doi:10.1016/j.cmi.2017.10.013
  • Zanella MC, Cordey S, Laubscher F, et al. Unmasking viral sequences by metagenomic next-generation sequencing in adult human blood samples during steroid-refractory/dependent graft-versus-host disease. Microbiome. 2021;9(1):28. doi:10.1186/s40168-020-00953-3
  • Wang C, You Z, Fu J, et al. Application of metagenomic next-generation sequencing in the diagnosis of pulmonary invasive fungal disease. Front Cell Infect Microbiol. 2022;12:949505. doi:10.3389/fcimb.2022.949505
  • Zhang M, Wang Z, Wang J, et al. The value of metagenomic next-generation sequencing in hematological malignancy patients with febrile neutropenia after empiric antibiotic treatment failure. Infect Drug Resist. 2022;15:3549–3559. doi:10.2147/IDR.S364525
  • Liu Y, Zhang J, Han B, et al. Case report: diagnostic value of metagenomics next generation sequencing in intracranial infection caused by mucor. Front Med. 2021;8:682758. doi:10.3389/fmed.2021.682758
  • Sun Y, Li H, Chen J, et al. Case report: metagenomics next-generation sequencing can be performed for the diagnosis of disseminated mucormycosis. Front Med. 2021;8:675030. doi:10.3389/fmed.2021.675030
  • Wen B, Cai L, Cai Y, Du X. Case report: metagenomics next-generation sequencing for diagnosing cerebral infarction and infection caused by hematogenous disseminated mucormycosis in a patient with acute lymphoblastic leukemia. Front Med. 2021;8:779981. doi:10.3389/fmed.2021.779981
  • Chen L, Su Y, Xiong XZ. Rhizopus microsporus lung infection in an immunocompetent patient successfully treated with amphotericin B: a case report. World J Clin Cases. 2021;9(35):11108–11114. doi:10.12998/wjcc.v9.i35.11108
  • Zhang J, Luo J, Weng X, et al. A case report of the metagenomics next-generation sequencing for early detection of central nervous system mucormycosis with successful rescue in patient with recurrent chronic lymphocytic leukemia. Ann Transl Med. 2022;10(12):722. doi:10.21037/atm-22-2533
  • Li N, Cai Q, Miao Q, Song Z, Fang Y, Hu B. High-throughput metagenomics for identification of pathogens in the clinical settings. Small Methods. 2021;5(1):2000792. doi:10.1002/smtd.202000792